[恶性梗阻性黄疸：经皮金属支架的作用]
[Malignant obstructive jaundice: the role of percutaneous metallic stents].
作者信息
D'alincourt A, Hamy A, Thibaud C, Redon H, Paineau J, Lerat F
机构信息
Service de Radiologie Générale, Hôpital Guillaume-et-René Laennec, Nantes.
出版信息
Gastroenterol Clin Biol. 2000 Aug-Sep;24(8-9):770-5.
OBJECTIVES
Efficiency evaluation of percutaneous metallic stents in palliative treatment of malignant biliary obstruction.
METHODS
One hundred sixteen percutaneous metallic stents were implanted in 80 patients with malignant biliary obstruction. Thirty-five patients had hilar obstruction, 32 patients obstruction of the common bile duct and 12 patients obstruction of a bilioenteric anastomosis.
RESULTS
Adequate biliary drainage was achieved in 79 patients. Early complications occurred in 23.75% of patients; 12.5% of patients died within 30 days. The procedure-related mortality rate was 5%; 18.75% of patients showed recurrent jaundice after an average of 175 days.
CONCLUSION
Percutaneous metallic stents are an efficient means of treating malignant biliary strictures, particularly of upper biliary obstructions. However, this treatment has risks and limits that require careful patient recruitment.
目的
评估经皮金属支架在恶性胆道梗阻姑息治疗中的有效性。
方法
对80例恶性胆道梗阻患者植入116枚经皮金属支架。35例为肝门部梗阻，32例为胆总管梗阻，12例为胆肠吻合口梗阻。
结果
79例患者实现了充分的胆道引流。23.75%的患者发生早期并发症；12.5%的患者在30天内死亡。手术相关死亡率为5%；18.75%的患者平均在175天后出现复发性黄疸。
结论
经皮金属支架是治疗恶性胆道狭窄，尤其是上段胆道梗阻的有效手段。然而，这种治疗存在风险和局限性，需要谨慎选择患者。
Zotero 插件